Dodson, Morgan
(2017)
Going forward with the AACI: routes for improvement and the role of human genetics in delivery of cancer care.
Master Essay, University of Pittsburgh.
|
Microsoft Word
Submitted Version
Available under License : See the attached license file.
Download (441kB)
|
|
Plain Text (licence)
Available under License : See the attached license file.
Download (1kB)
|
Abstract
Cancer is the 2nd leading cause of death in the United States, and accounts for over 5% of health spending in the U.S. Further, both the disease and financial burden of cancer are predicted to grow in the coming years as the population ages and expensive new treatments are developed. While genomics will play a key role in understanding and treating cancer going forward, recent opinions of cancer treatment also reflect a focus on increasing the efficiency of treatment and strengthening the oncology infrastructure. Meeting these goals will be crucial to the maintenance of Public Health. The Association of American Cancer Institutes (AACI) epitomizes this outlook, and seeks to improve prevention, detection, and treatment of cancer by supporting academic-based cancer centers that receive support from the Nation Cancer Institute (NCI). Their Physician Clinical Leadership Initiative (PCLI) furthers this goal by uniting center leadership and helping them to share vital experience across the nation. As part of this essay, I analyzed data from a self-assessment exercise performed by PCLI at their 2016 annual meeting. Analysis revealed insight into where physician leaders felt their centers were positioned in several key subject areas (such as oncology quality programs, clinical operations, and translating research into practice), where they felt their centers should be, where there was variation in the state of centers across the nation according to physician leadership, and the extent of agreement or disagreement among centers regarding their goals. These results will be used to assess which subject areas are priority targets for improvement. Finally, AACI also reflects the advancing role of genomics in cancer care through their Molecular Diagnostics Initiative.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
Other Thesis, Dissertation, or Long Paper
(Master Essay)
|
Status: |
Unpublished |
Creators/Authors: |
|
Contributors: |
Contribution | Contributors Name | Email | Pitt Username | ORCID |
---|
Committee Chair | Kammerer, Candace | cmk3@pitt.edu | cmk3 | UNSPECIFIED | Committee Member | Diergaarde, Brenda | bbd3@pitt.edu | bbd3 | UNSPECIFIED |
|
Date: |
27 April 2017 |
Date Type: |
Submission |
Defense Date: |
14 April 2017 |
Submission Date: |
2 April 2017 |
Access Restriction: |
No restriction; Release the ETD for access worldwide immediately. |
Publisher: |
University of Pittsburgh |
Institution: |
University of Pittsburgh |
Schools and Programs: |
School of Public Health > Human Genetics |
Degree: |
MPH - Master of Public Health |
Thesis Type: |
Master Essay |
Refereed: |
Yes |
Uncontrolled Keywords: |
Cancer, Human, Genetics, Association, of, American, Cancer, Institutes |
Date Deposited: |
14 Jul 2017 19:15 |
Last Modified: |
31 May 2022 17:55 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/31159 |
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
|
View Item |